SEC Form 4 · accession 0001209191-18-036828
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Lawrence
Officer — Chief, Bus. Ops & PAO
Period of report
Jun 7, 2018
Accepted (ET)
Jun 11, 2018 · 7:44 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 7, 2018 | M | 19,880 | $20.59 | A | 28,004 | D | |
| Common StockF1,F2 | Jun 7, 2018 | S | 19,880 | $28.0169 | D | 8,124 | D | |
| Common StockF1 | Jun 8, 2018 | M | 5,120 | $20.59 | A | 13,244 | D | |
| Common StockF1,F3 | Jun 8, 2018 | S | 4,000 | $28.4075 | D | 9,244 | D | |
| Common StockF1,F4 | Jun 8, 2018 | S | 400 | $29.6125 | D | 8,844 | D | |
| Common StockF1,F5 | Jun 8, 2018 | S | 500 | $30.58 | D | 8,344 | D | |
| Common StockF1,F6 | Jun 8, 2018 | S | 200 | $31.90 | D | 8,144 | D | |
| Common StockF1 | Jun 8, 2018 | S | 20 | $33.10 | D | 8,124 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F7 | $20.59 | Jun 7, 2018 | M | 19,880 | D | — | Mar 2, 2019 | Common Stock | 19,880 | 5,120 | D |
| Employee Stock Option (right to buy)F1,F7 | $20.59 | Jun 8, 2018 | M | 5,120 | D | — | Mar 2, 2019 | Common Stock | 5,120 | 0 | D |
Explanation of responses
- F1Exercises and sales pursuant to a 10b5-1 plan.
- F2The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $28.00 to $28.20 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $28.30 to $29.10 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $29.30 to $30.20 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F5The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $30.35 to $31.00 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F6The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.70 to $32.10 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F7The shares subject to these options vested in installments and were fully vested on 01/01/2013.